Vanaja V. Ragavan
Fondateur chez Aviana Molecular Technologies LLC
Profil
Vanaja V.
Ragavan is the founder of Aviana Molecular Technologies LLC, which was founded in 2008, where she holds the titles of President, Chief Executive Officer & Director.
She is currently the President & Chief Executive Officer of Aviana Holdings, Inc. Dr. Ragavan's former positions include being a Principal at Aventis, Inc., Novartis Corp., and Wyeth-Ayerst Research, as well as being the Chief Medical Officer at Neuro Diagnostic Devices, Inc. Dr. Ragavan received her undergraduate degree from Harvard University and her doctorate from New York University.
Postes actifs de Vanaja V. Ragavan
| Sociétés | Poste | Début |
|---|---|---|
Aviana Molecular Technologies LLC
 Aviana Molecular Technologies LLC Medical SpecialtiesHealth Technology Aviana Molecular Technologies LLC develops technologies for point of care diagnostic of infections. It develops a miniaturized biosensor capable of attaching to a smartphone or smart device through Bluetooth or other wireless connections. The company's diagnostic system is a diagnostic platform that can accurately, detect a target infectious disease, biomarkers or proteins in both clinical and scientific research settings. Its platform uses the latest developments in cellular communications, semiconductor electronics, micro-fluidics and manufacturing methods to create a unique point-of-care diagnostic platform to detect biomarkers or infections. The company was founded by Vanaja Ragavan in 2008 and is headquartered in Orlando, FL. | Fondateur | 01/01/2008 |
Aviana Holdings, Inc.
 Aviana Holdings, Inc. Medical SpecialtiesHealth Technology Aviana Holdings, Inc. operates as a diagnostic company. The firm developes miniaturized biosensor capable of attaching to a smartphone or smart device through bluetooth or other wireless connections. The company is headquartered in Orlando, FL. | Directeur Général | - |
Anciens postes connus de Vanaja V. Ragavan
| Sociétés | Poste | Fin |
|---|---|---|
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
| Wyeth-Ayerst Research | Corporate Officer/Principal | - |
| Aventis, Inc. | Corporate Officer/Principal | - |
Neuro Diagnostic Devices, Inc.
 Neuro Diagnostic Devices, Inc. Medical SpecialtiesHealth Technology Neuro Diagnostic Devices, Inc. provides medical devices. Its product ShuntCheck is an aid to the detection of flow in implanted cerebrospinal fluid (CSF) shunts. The company was founded by Samuel R. Neff and Frederick J. Fritz on May 16, 2005 and is headquartered in Princeton, NJ. | Directeur Technique/Scientifique/R&D | - |
Formation de Vanaja V. Ragavan
| Harvard University | Undergraduate Degree |
| New York University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
| Aventis, Inc. | |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
| Wyeth-Ayerst Research | |
Neuro Diagnostic Devices, Inc.
Neuro Diagnostic Devices, Inc. Medical SpecialtiesHealth Technology Neuro Diagnostic Devices, Inc. provides medical devices. Its product ShuntCheck is an aid to the detection of flow in implanted cerebrospinal fluid (CSF) shunts. The company was founded by Samuel R. Neff and Frederick J. Fritz on May 16, 2005 and is headquartered in Princeton, NJ. | Health Technology |
Aviana Molecular Technologies LLC
Aviana Molecular Technologies LLC Medical SpecialtiesHealth Technology Aviana Molecular Technologies LLC develops technologies for point of care diagnostic of infections. It develops a miniaturized biosensor capable of attaching to a smartphone or smart device through Bluetooth or other wireless connections. The company's diagnostic system is a diagnostic platform that can accurately, detect a target infectious disease, biomarkers or proteins in both clinical and scientific research settings. Its platform uses the latest developments in cellular communications, semiconductor electronics, micro-fluidics and manufacturing methods to create a unique point-of-care diagnostic platform to detect biomarkers or infections. The company was founded by Vanaja Ragavan in 2008 and is headquartered in Orlando, FL. | Health Technology |
Aviana Holdings, Inc.
Aviana Holdings, Inc. Medical SpecialtiesHealth Technology Aviana Holdings, Inc. operates as a diagnostic company. The firm developes miniaturized biosensor capable of attaching to a smartphone or smart device through bluetooth or other wireless connections. The company is headquartered in Orlando, FL. | Health Technology |